←Back to Expert Scholars
Translational Medicine / 转化医学Lung Oncogenic Fusions
Christine Lovly
MD, PhD
🏢Vanderbilt-Ingram Cancer Center🌐USA
Associate Professor of Medicine
55
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Christine Lovly is a physician-scientist at Vanderbilt studying ALK and other fusion oncogenes. Her lab dissects resistance mechanisms and develops novel combination strategies. She leads investigator-initiated fusion oncogene trials.
Share:
🧪Research Fields 研究领域
ALK fusions
Fusion biology
Resistance mechanisms
Translational research
Preclinical models
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Christine Lovly 的研究动态
Follow Christine Lovly's research updates
留下邮箱，当我们发布与 Christine Lovly（Vanderbilt-Ingram Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment